Viewing nowPosiel Tablet 5mg (Dapagliflozin Propane Diol Hydrate)
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

MFDS item code 202300336 · Approved 2023.01.25 · Insurance code 649702970
Treatment of type 2 diabetes mellitus, chronic kidney disease, and chronic heart failure
This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. Additionally, in patients with chronic heart failure, it helps reduce the risk of death and hospitalization due to cardiovascular diseases. It is also used in patients with chronic kidney disease to slow the progression of kidney function decline and reduce the risk of cardiovascular and kidney-related mortality. This drug can be administered alone or in combination with other standard treatments, enhancing the therapeutic effect for each condition. Overall, it is effectively used for the treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of pharmacological treatment for diabetes, when this medicine is administered in combination with metformin, the recommended initial dose is 5 mg once daily or 10 mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablets should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in certain patients. Patients allergic to the main ingredient or additives, those with type 1 diabetes or diabetic ketoacidosis, should avoid this medication due to potential risks. Moreover, it contains anhydrous lactose, making it unsuitable for patients with genetic conditions such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Patients undergoing dialysis should also not use this medication. Patients with reduced fluid volume or kidney function issues should use this medication cautiously. It can lower blood pressure or temporarily worsen kidney function; therefore, elderly patients or those taking diuretics must be especially careful. Before starting this medication, evaluate fluid status and kidney function, and after administration, continuously monitor for symptoms of low blood pressure and kidney function. Patients with moderate to severe kidney impairment may experience reduced blood sugar control effectiveness. Common side effects of this medication include genital infections and urinary tract infections. Women and patients with a history of infections should be particularly cautious as the risk of reinfection may be higher. Hypoglycemia symptoms may occur, particularly if taken with insulin or sulfonylureas, increasing the risk of hypoglycemia. Symptoms of reduced fluid volume or dehydration have also been reported, so it is important to consult medical professionals immediately if dehydration symptoms occur. Rarely, serious metabolic disturbances like diabetic ketoacidosis may develop, requiring immediate medical attention if symptoms like nausea, vomiting, abdominal pain, or breathing difficulties occur. Additionally, symptoms such as pain, swelling, or redness in the perineum indicate a serious infection like perineal necrosis, necessitating immediate treatment. This medication is not recommended for patients with severely impaired liver function. Elderly patients, those with low blood pressure, or patients on diuretics must be particularly cautious of blood pressure drops and reduced fluid volume. It is safest for pregnant or breastfeeding women to avoid this medication, and the safety and efficacy in children have not yet been established. This medication can interact with other drugs, so especially when taken with diuretics, insulin, or sulfonylureas, dosage adjustments may be necessary. In case of overdose, there are no specific antidotes; treatment should be symptomatic, following medical guidance. During the use of this medication, closely monitor for symptoms of hypoglycemia and infection, and consult medical staff immediately if any abnormal symptoms arise. Finally, it is important to keep this medication out of the reach of children and store it in its original container to maintain quality.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased creatinine clearance at the start of treatment, dyslipidemia, elevated serum creatinine at the start of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, malaise, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, depression, suicide attempts, gastric adenocarcinoma, anaphylactic reactions, chest pain, chest discomfort, edema, foreign body sensation, facial edema, facial pain, warmth, flu-like syndrome, breast masses, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcers, abnormal sweating eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteoporosis, muscle weakness, bruising, traffic accidents, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, iliac fracture, laceration, ligament rupture, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic spine fracture, tibial fracture, dental injury, dry eye, eye pain, retinal disorders, visual impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, vitreous floaters, oral pharyngeal pain, allergic rhinitis, asthma, speech disorders, epistaxis, sputum, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, palpitations, anxiety disorders, nocturia, insomnia, fatty liver, gallbladder polyps, tinnitus, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased blood lactate, lymphocytopenia, decreased appetite, thirst, headache, sensory loss, paresthesia, nasopharyngitis, upper respiratory infections, hunger, vaginal discharge, pruritus, arthralgia, musculoskeletal pain, limb pain, myalgia, osteoarthritis, sprains, diabetic retinopathy, cough, dyspnea
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to store it at room temperature between 1°C and 30°C.
Yellow, film-coated, round tablets that are biconvex on both sides
28 tablets/PTP [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
GL Pharma Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.